ELLINGTON MANAGEMENT GROUP LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 88 filers reported holding REVANCE THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 1.5%.

Quarter-by-quarter ownership
ELLINGTON MANAGEMENT GROUP LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$303,000
+73.1%
23,300
+109.9%
0.06%
+71.9%
Q1 2019$175,000
-48.7%
11,100
-32.3%
0.03%
+166.7%
Q1 2017$341,000
-44.2%
16,400
-14.1%
0.01%
-91.9%
Q2 2015$611,00019,1000.15%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$20,260,00052.86%
Essex Woodlands Management, Inc. 3,342,047$43,447,00027.06%
Sio Capital Management, LLC 305,664$3,974,0001.28%
Fosun International Ltd 472,532$6,143,0000.68%
ArrowMark Colorado Holdings LLC 4,831,653$62,811,0000.63%
RICE HALL JAMES & ASSOCIATES, LLC 1,078,697$14,023,0000.50%
Rhenman & Partners Asset Management AB 173,917$2,261,0000.28%
HARBOURVEST PARTNERS LLC 26,365$343,0000.14%
FIRST MIDWEST BANK TRUST DIVISION 67,141$873,0000.13%
Rock Creek Group, LP 18,500$241,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders